BIOR Biora Therapeutics
- 0.7128
- +0.0708+11.03%
- 0.7120
- -0.0008-0.11%
Biora Therapeutics News
Biora Therapeutics Receives Buy Rating Amid Positive Clinical Progress and Promising Drug Delivery Innovations
Analysts' Top Healthcare Picks: Biora Therapeutics (BIOR), Irhythm Technologies (IRTC)
BTIG Keeps Their Buy Rating on Biora Therapeutics (BIOR)
HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $50 Price Target
Biora Therapeutics Analyst Ratings
Biora Therapeutics (BIOR) Receives a Buy From BTIG
Analysts Offer Insights on Healthcare Companies: Biora Therapeutics (BIOR), Bolt Biotherapeutics (BOLT) and Immunovant (IMVT)
HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Lowers Price Target to $50
Biora Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Omega Therapeutics (OMGA) and Biora Therapeutics (BIOR)
HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $65 Price Target
Biora Therapeutics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH), Clearside Biomedical (CLSD) and Biora Therapeutics (BIOR)
Biora Therapeutics Analyst Ratings
H.C. Wainwright Sticks to Its Buy Rating for Biora Therapeutics (BIOR)
H.C. Wainwright Remains a Buy on Biora Therapeutics (BIOR)
Analysts Are Bullish on These Healthcare Stocks: Biora Therapeutics (BIOR), IN8bio (INAB)
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Genfit SA (GNFT) and Biora Therapeutics (BIOR)
Analysts Are Bullish on Top Healthcare Stocks: Biora Therapeutics (BIOR), Rani Therapeutics Holdings (RANI)
Biora Therapeutics Analyst Ratings
Analysis
Price Target
No Data
